3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is growing attracting researcher focus due to initial evidence suggesting unique physiological actions. Preliminary studies suggest that 3-HPC may display separate impacts on the central nervous system, arguably playing a role t